← All stocks

Vaxcyte, Inc.

PCVX Net selling
CIK 0001649094 #979 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$9.09M
$2.25M on a plan · $5.66M straight out of an exercise
Sold at will
$1.18M
5 of 50 sales
Net
−$9.09M
−$1.18M against sales at will

By person

15 insiders · 51 transactions
51.8×

Grant E. Pickering holds 51.8 times base salary in stock. $41.45M of shares against $800.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Grant E. Pickering last reported holding, valued at $59.52, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
PICKERING GRANT
CHIEF EXECUTIVE OFFICER
$3.63M (19) scheduled
−$3.63M
696,332
0.4679%
$41.45M
−7.2%
GUGGENHIME ANDREW
PRESIDENT AND CFO
$1.64M (5) scheduled
−$1.64M
219,016
0.1472%
$13.04M
+42.8%
Wassil Jim
EVP, Chief Scientific Ofc, COO
$1.43M (18) scheduled
−$1.43M
145,435
0.0977%
$8.66M
−26.1%
Dhaliwal Harpreet S.
Chief Technical Ops Officer
$1.39M (2) scheduled
−$1.39M
68,085
0.0458%
$4.05M
+83.1%
Cowan Elvia
SVP, Finance & CAO
$988.60K (6)
−$988.60K
27,860
0.0187%
$1.66M
+120.3%
Jodar Luis
Chief Medical Officer
52,632
0.0354%
$3.13M
Eydelman Mikhail
SVP, GEN COUNSEL & CORP SEC
41,620
0.0280%
$2.48M
+44.5%
Lukatch Heath
Director
19,481
0.0131%
$1.16M
+171.5%
Paya Carlos V
Director
12,481
0.0084%
$742.88K
+74.0%
Gilbert Halley E
Director
12,481
0.0084%
$742.88K
+74.0%
Loxam Teri
Director
12,481
0.0084%
$742.88K
+74.0%
Drapeau Anne S
Director
12,481
0.0084%
$742.88K
+74.0%
Lee Jacks
Director
6,856
0.0046%
$408.08K
+342.3%
Furey John
Director
5,306
0.0036%
$315.82K
BRANDICOURT OLIVIER
Director
4,699
0.0032%
$279.69K
Insider
Date
Role
Action
Shares
Price
Amount
Cowan Elvia
26 Feb 2026
SVP, Finance & CAO
Exercised, kept
7,716
$25.92
$200.00K

What was left out

Form 4 filings counted 50
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 18
Sales straight out of an exercise 27
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 700,754
History held since 15 Jun 2020